At Least Two Drugs Companies Would Probably Say "No"
ROCKVILLE, MD-Two prescription drugs were either restricted or removed from the market last week prompting questions of whether the warning labels issued with the drugs are being overlooked. The withdrawal of Rezulin and the restrictive usage of Propulsid have prompted the Food and Drug Administration (FDA) to renew its efforts to make sure the labeling process is effective. Currently when a drug is packaged, it includes an information sheet explaining the drug's usage, warnings, and possible side effects. For example, Propulsid was marketed for severe nighttime heartburn in adults and its label was strengthened five times since it was approved to warn physicians about prescribing it to patients at risk of heart problems. Yet the FDA found several fatal cases of children who were prescribed Propulsid and cases of adults with potential heart conditions who had been prescribed the drug.
In each case, once problems started to occur, the FDA and the marketing company relabeled the drug. The label was reworded and physicians were notified either through FDA press releases or letters sent directly by the marketing company. Whether this is an effective means of communication, though, seems to be questionable. Doctors are overwhelmed by paperwork and a new drug information sheet may go unnoticed. The FDA believes the problem stems from the majority of physicians referencing the Physicians' Desk Reference, a monthly publication, instead of the actual drug labels.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
IP LifeLine: Layoffs and the Evolving Job Market Landscape for Infection Preventionists
July 11th 2025Infection preventionists, once hailed as indispensable during the pandemic, now face a sobering reality: budget pressures, hiring freezes, and layoffs are reshaping the field, leaving many IPs worried about their future and questioning their value within health care organizations.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.